Abstract
High Lactate Dehydrogenase (LDH) activity, a distinct feature of cancer cells, is a possible causative factor for cancer cells to metastasize, infiltrate, invade, and deteriorate. The exploration of upconversion hybrid nano fluorescent sensor (HNFS) with the capability of evaluation the LDH inhibitors efficacy will be useful to accelerate the development of anti-cancer drugs from LDH inhibitors. Herein, we design an HNFS that can evaluate the inhibitors efficacy in vitro from the changes of the upconversion luminescence in the red-light region. HNFS is composed of two components: a Nile Blue A derivative (CPNB) that detects LDH activity, and tailored manganese doped upconverting nanoparticles that produce bright red emission which absorbs by CPNB via Förster resonance energy transfer. The cytotoxicity of HNFS in living cells (HeLa, A549 and Ges-1) was investigated by using the CCK-8 assay, which showed that HNFS possesses excellent biocompatibility. After incubating HNFS with three types of cells (A549, HeLa, and Ges-1), the mean fluorescence intensities of confocal images in vitro can illustrate the efficacy of LDH inhibitors to different cancer cells and distinguish healthy cells (Ges-1) from cancer cells (A549 and HeLa). Therefore, the systematic study of HNFS in vitro does encourage the potential applications of evaluating the LDH inhibitors efficacy in cancer cells.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
